{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:02Z","timestamp":1772165702609,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Nursery Fund of People's Liberation Army General Hospital","award":["15KMM01"],"award-info":[{"award-number":["15KMM01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adrenoleukodystrophy is a rare neurogenetic disease, AMN is the most common adult phenotype, such patients in China have not gotten enough attention. This article aims to study the features of AMN in Chinese patients and expand the gene spectrum of Chinese X-linked adrenoleukodystrophy (X-ALD) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We applied clinical analysis, radiology, plasma levels of very long chain fatty acids (VLCFA) and genetic analysis to test the 6 Chinese AMN patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All 6 patients are men. Ages of neurological symptom onset are distributed between 21 and 38. Sexual dysfunction occurred in 5 of 6 patients. Three patients had positive family history. Five patients had Addison\u2019s disease. Four patients were diagnosed as pure AMN, while the other two patients were with cerebral involvement. Four patients had abnormalities of nerve conduction studies. There were four patients with central conduction defects in somatosensory evoked potential tests. All 6 patients were found diffuse cord atrophy in spinal MRI. Brain MRI showed abnormal signals in 2 of the 6 tested patients, which indicated the clinical phenotypes. Plasma levels of VLCFA, as well as C24:0\/C22:0 and C26:0\/C22:0 ratios were elevated in 5 tested patients. Five different ABCD1 mutations were identified in 5 tested patients, one of which was a de novo mutation, and the other four have been reported previously.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This research described the clinical, neuroimaging, biochemical, and genetic sides of Chinese AMN patients. A de novo mutation in the ABCD1 gene sequence was identified. Emotional trauma may trigger or aggravate the development of cerebral demyelination in AMN patients. Regular evaluation of brain MRI is important for AMN patients, especially for \u2018pure AMN\u2019 patients. When encountering patients with \u2018myeloneuropathy-only\u2019, neurologists should not ignore the tests of VLCFA or\/and the ABCD1 gene.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-019-1449-5","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T06:04:21Z","timestamp":1568613861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical, neuroimaging, biochemical, and genetic features in six Chinese patients with Adrenomyeloneuropathy"],"prefix":"10.1186","volume":"19","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zizi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"issue":"8","key":"1449_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/brain\/120.8.1485","volume":"120","author":"HW Moser","year":"1997","unstructured":"Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain. 1997;120(8):1485\u2013508.","journal-title":"Brain"},{"issue":"1","key":"1449_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/jnnp.63.1.4","volume":"63","author":"BM van Geel","year":"1997","unstructured":"van Geel BM, Assies J, Wanders RJ, Barth PG. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry. 1997;63(1):4\u201314.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1449_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF00312873","volume":"213","author":"H Budka","year":"1976","unstructured":"Budka H, Sluga E, Heiss WD. Spastic paraplegia associated with Addison's disease: adult variant of adreno-leukodystrophy. J Neurol. 1976;213(3):237\u201350.","journal-title":"J Neurol"},{"issue":"12","key":"1449_CR4","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.27.12.1107","volume":"27","author":"JW Griffin","year":"1977","unstructured":"Griffin JW, Goren E, Schaumburg H, Engel WK, Loriaux L. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology. 1977;27(12):1107\u201313.","journal-title":"Neurology"},{"issue":"2","key":"1449_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/jnen\/59.2.89","volume":"59","author":"JM Powers","year":"2000","unstructured":"Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW. Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol. 2000;59(2):89\u2013102.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"1449_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/jnen\/60.5.493","volume":"60","author":"JM Powers","year":"2001","unstructured":"Powers JM, DeCiero DP, Cox C, et al. The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria. J Neuropathol Exp Neurol. 2001;60(5):493\u2013501.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1449_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1212\/01.WNL.0000149514.13580.84","volume":"64","author":"P Dubey","year":"2005","unstructured":"Dubey P, Fatemi A, Barker PB, et al. Spectroscopic evidence of cerebral axonopathy in patients with \u201cpure\u201d adrenomyeloneuropathy. Neurology. 2005;64(2):304\u201310.","journal-title":"Neurology"},{"issue":"1","key":"1449_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1212\/WNL.46.1.112","volume":"46","author":"BM van Geel","year":"1996","unstructured":"van Geel BM, Koelman JH, Barth PG, Ongerboer de Visser BW. Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study. Neurology. 1996;46(1):112\u20138.","journal-title":"Neurology"},{"issue":"2","key":"1449_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.61.2.181","volume":"61","author":"V Chaudhry","year":"1996","unstructured":"Chaudhry V, Moser HW, Cornblath DR. Nerve conduction studies in adrenomyeloneuropathy. J Neurol Neurosurg Psychiatry. 1996;61(2):181\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1449_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R","volume":"49","author":"BM van Geel","year":"2001","unstructured":"van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol. 2001;49(2):186\u201394.","journal-title":"Ann Neurol"},{"issue":"9","key":"1449_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","volume":"1822","author":"S Kemp","year":"2012","unstructured":"Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta. 2012;1822(9):1465\u201374.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"1449_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12041-010-0067-1","volume":"89","author":"N Kumar","year":"2010","unstructured":"Kumar N, Taneja KK, Kumar A, et al. Novel mutation in ATP-binding domain of ABCD1 gene in adrenoleukodystrophy. J Genet. 2010;89(4):473\u20137.","journal-title":"J Genet"},{"issue":"6","key":"1449_CR13","first-page":"1135","volume":"58","author":"V Feigenbaum","year":"1996","unstructured":"Feigenbaum V, Lombard-Platet G, Guidoux S, Sarde CO, Mandel JL, Aubourg P. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy. Am J Hum Genet. 1996;58(6):1135\u201344.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1449_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1172\/JCI117363","volume":"94","author":"P Fanen","year":"1994","unstructured":"Fanen P, Guidoux S, Sarde CO, Mandel JL, Goossens M, Aubourg P. Identification of mutations in the putative ATP-binding domain of the adrenoleukodystrophy gene. J Clin Invest. 1994;94(2):516\u201320.","journal-title":"J Clin Invest"},{"issue":"2","key":"1449_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/humu.1380060203","volume":"6","author":"F Kok","year":"1995","unstructured":"Kok F, Neumann S, Sarde CO, et al. Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum Mutat. 1995;6(2):104\u201315.","journal-title":"Hum Mutat"},{"issue":"6414","key":"1449_CR16","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser J, Douar AM, Sarde CO, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361(6414):726\u201330.","journal-title":"Nature"},{"issue":"10","key":"1449_CR17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1212\/WNL.31.10.1241","volume":"31","author":"HW Moser","year":"1981","unstructured":"Moser HW, Moser AB, Frayer KK, et al. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology. 1981;31(10):1241\u20139.","journal-title":"Neurology"},{"issue":"4","key":"1449_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ymgme.2017.10.012","volume":"122","author":"IC Huffnagel","year":"2017","unstructured":"Huffnagel IC, van de Beek M-C, Showers AL, et al. Comparison of C26: 0-carnitine and C26: 0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy. Mol Genet Metab. 2017;122(4):209\u201315.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"1449_CR19","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1212\/WNL.27.12.1114","volume":"27","author":"HH Schaumburg","year":"1977","unstructured":"Schaumburg HH, Powers JM, Raine CS, et al. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology. 1977;27(12):1114\u20139.","journal-title":"Neurology"},{"issue":"2","key":"1449_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1006\/bbrc.1994.1979","volume":"202","author":"S Kemp","year":"1994","unstructured":"Kemp S, Ligtenberg MJ, van Geel BM, et al. Identification of a two base pair deletion in five unrelated families with adrenoleukodystrophy: a possible hot spot for mutations. Biochem Biophys Res Commun. 1994;202(2):647\u201353.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1449_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1023\/A:1022535930009","volume":"24","author":"KD Smith","year":"1999","unstructured":"Smith KD, Kemp S, Braiterman LT, et al. X-linked adrenoleukodystrophy: genes, mutations, and phenotypes. Neurochem Res. 1999;24(4):521\u201335.","journal-title":"Neurochem Res"},{"issue":"3","key":"1449_CR22","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1006\/bbrc.1994.2855","volume":"205","author":"J Berger","year":"1994","unstructured":"Berger J, Molzer B, Fae I, Bernheimer H. X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Commun. 1994;205(3):1638\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1449_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ana.410400221","volume":"40","author":"GC Korenke","year":"1996","unstructured":"Korenke GC, Fuchs S, Krasemann E, et al. Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann Neurol. 1996;40(2):254\u20137.","journal-title":"Ann Neurol"},{"issue":"4\u20135","key":"1449_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000112170","volume":"13","author":"HW Moser","year":"1991","unstructured":"Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci. 1991;13(4\u20135):254\u201361.","journal-title":"Dev Neurosci"},{"key":"1449_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-981-10-7668-8_23","volume-title":"Emergency Neuro-ophthalmology","author":"An-Guor Wang","year":"2018","unstructured":"Wang AG. X-Linked Adrenoleukodystrophy[M]\/\/Emergency Neuro-ophthalmology. Singapore: Springer; 2018. p. 137-41."},{"issue":"24","key":"1449_CR26","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1212\/WNL.0000000000001074","volume":"83","author":"M de Beer","year":"2014","unstructured":"de Beer M, Engelen M, van Geel BM. Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy. Neurology. 2014;83(24):2227\u201331.","journal-title":"Neurology"},{"issue":"1\u20132","key":"1449_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jns.2009.11.005","volume":"290","author":"GV Raymond","year":"2010","unstructured":"Raymond GV, Seidman R, Monteith TS, et al. Head trauma can initiate the onset of adreno-leukodystrophy. J Neurol Sci. 2010;290(1\u20132):70\u20134.","journal-title":"J Neurol Sci"},{"issue":"22","key":"1449_CR28","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1212\/WNL.0000000000002173","volume":"85","author":"F Bouquet","year":"2015","unstructured":"Bouquet F, Dehais C, Sanson M, Lubetzki C, Louapre C. Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma. Neurology. 2015;85(22):1991\u20133.","journal-title":"Neurology"},{"issue":"10","key":"1449_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrendo.2016.90","volume":"12","author":"S Kemp","year":"2016","unstructured":"Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M. Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol. 2016;12(10):606\u201315.","journal-title":"Nat Rev Endocrinol"},{"key":"1449_CR30","doi-asserted-by":"crossref","unstructured":"van der Knaap MS VJ. X-linked adrenoleukodystrophy. In Magnetic Resonance of Myelination and Myelin Disorders. 3rd edition. Edited by Heilmann U. Berlin-Heidelberg-New York. Springer 2005: 176\u201390.","DOI":"10.1007\/3-540-27660-2_21"},{"key":"1449_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-319-76148-0_3","volume-title":"Neurometabolic Hereditary Diseases of Adults","author":"Renzo Manara","year":"2018","unstructured":"Manara R, Burlina AP. Neuroimaging of inherited metabolic diseases of adulthood[M]\/\/Neurometabolic hereditary diseases of adults. Cham: Springer; 2018. p. 43-65."},{"key":"1449_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1172-7-51","volume":"7","author":"M Engelen","year":"2012","unstructured":"Engelen M, Kemp S, de Visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012;7:51.","journal-title":"Orphanet J Rare Dis"},{"key":"1449_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.12659\/PJR.893285","volume":"80","author":"J Bladowska","year":"2015","unstructured":"Bladowska J, Kulej D, Biel A, et al. The role of MR imaging in the assessment of clinical outcomes in children with X-linked adrenoleukodystrophy after allogeneic haematopoietic stem cell transplantation. Pol J Radiol. 2015;80:181.","journal-title":"Pol J Radiol"},{"issue":"3","key":"1449_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1212\/01.WNL.0000079050.91337.83","volume":"61","author":"DJ Loes","year":"2003","unstructured":"Loes DJ, Fatemi A, Melhem ER, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology. 2003;61(3):369\u201374.","journal-title":"Neurology"},{"issue":"10","key":"1449_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamaneurol.2018.1585","volume":"75","author":"Ann B. Moser","year":"2018","unstructured":"Moser AB, Fatemi A. Newborn screening and emerging therapies for X-linked Adrenoleukodystrophy[J]. JAMA Neurol. 2018;75(10):1175-6.","journal-title":"JAMA Neurology"},{"issue":"3","key":"1449_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/jnnp.67.3.290","volume":"67","author":"BM van Geel","year":"1999","unstructured":"van Geel BM, Assies J, Haverkort EB, et al. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with \u201cLorenzo\u2019s oil\u201d. J Neurol Neurosurg Psychiatry. 1999;67(3):290\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1449_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/8904_2017_32","volume":"38","author":"M Morita","year":"2018","unstructured":"Morita M, Honda A, Kobayashi A, et al. Effect of Lorenzo\u2019s oil on hepatic gene expression and the serum fatty acid level in abcd1-deficient mice. JIMD Rep. 2018;38:67\u201374.","journal-title":"JIMD Rep"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1449-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1449-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1449-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T19:08:20Z","timestamp":1600110500000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1449-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1449"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1449-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.295\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.295\/v2","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]},"assertion":[{"value":"25 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients or their lineal relatives signed written informed consent. For participants who were unable to provide informed consent due to medical condition or severe dementia, participation was based on proxy consent given by family proxies. The study protocol has been approved by the Institutional Review Board of Chinese PLA General Hospital. The reference numbers for the ethical approval is S2016\u2013021-01.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all patients or their lineal relatives for publication of this article and any accompanying images. Due to intelligence deficits, the informed consent was signed by family proxies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"227"}}